Michael J. Detke - 10 Aug 2021 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
Chief Medical Officer
Signature
/s/ Caryn Gordon McDowell, Attorney-in-Fact for Michael J. Detke, M.D.
Issuer symbol
QNCX
Transactions as of
10 Aug 2021
Net transactions value
-$977,700
Form type
4
Filing time
12 Aug 2021, 17:37:22 UTC
Previous filing
07 Jul 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QNCX Common Stock Options Exercise $22,300 +10,000 $2.23 10,000 10 Aug 2021 Direct
transaction QNCX Common Stock Sale $1,000,000 -10,000 -100% $100.00* 0 10 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Options Exercise $0 -10,000 -9.8% $0.000000 92,352 10 Aug 2021 Common Stock 10,000 $2.23 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2021.
F2 The option will vest as to 25% of the shares on November 15, 2019, with the remaining 75% of shares vesting in equal monthly installments beginning on December 15, 2019 and ending on November 15, 2022.